Platelet-cancer Crosstalk: Mechanisms and Therapeutic Implications
Access Status
Open access
Authors
Elaskalani, Omar
Date
2019Supervisor
Pat Metharom
Type
Thesis
Award
PhD
Metadata
Show full item recordFaculty
Health Sciences
School
School of Pharmacy and Biomedical Sciences
Collection
Abstract
Platelets are small anucleate blood cells that are central to primary haemostasis. However, platelets are also implicated in cancer pathogenesis. This thesis showed that cancer cells promote thrombosis by activating platelets, and in turn, platelets provide cancer cells with growth factors to render cancer more aggressive and chemoresistant. The thesis demonstrated a therapeutic benefit of combined antiplatelet, ticagrelor, and chemo drugs, on cancer treatment.
Related items
Showing items related by title, author, creator and subject.
-
Elaskalani, Omar; Falasca, Marco; Moran, N.; Berndt, Michael; Metharom, Pat (2017)Platelets have been demonstrated to be vital in cancer epithelial-mesenchymal transition (EMT), an important step in metastasis. Markers of EMT are associated with chemotherapy resistance. However, the association between ...
-
Walsh, T.; Metharom, Pat; Berndt, Michael (2015)Functionally, platelets are primarily recognized as key regulators of thrombosis and hemostasis. Upon vessel injury, the typically quiescent platelet interacts with subendothelial matrix to regulate platelet adhesion, ...
-
Razak, N.; Elaskalani, O.; Metharom, Pat (2017)Pancreatic cancer (PaCa) is a highly metastatic cancer, and patients are at high risk of developing venous thromboembolism (VTE). Neutrophil extracellular traps (NETs) have been associated with cancer metastasis and ...